Anna Raciborska
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) (NCT05968768) | Anna Raciborska | 2023-10-24 |
| Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis (NCT04943198) | Anna Raciborska | 2021-04-01 |
| Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging (NCT04943211) | Anna Raciborska | 2021-04-01 |
| Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients (NCT04943224) | Anna Raciborska | 2021-04-01 |
Track Anna Raciborska automatically
Every clearance here is in the API, with alerts when new ones post.